- PLN317.70m
- PLN367.30m
- PLN207.76m
- 19
- 56
- 49
- 32
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.54 | ||
| Price to Tang. Book | 1.26 | ||
| Price to Free Cashflow | 12.64 | ||
| Price to Sales | 1.53 | ||
| EV to EBITDA | 12.01 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.88% | ||
| Return on Equity | -2.62% | ||
| Operating Margin | -2.75% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | 221.79 | 163.03 | 233.16 | 181.64 | 207.76 | n/a | n/a | 0.56% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -78.18 | +46.23 | -77.2 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bioton SA is a Poland-based company active in the pharmaceutical sector. The Company is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The Company's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.
Directors
- Jeremy Launders CMG
- Dariusz Trzeciak VSU
- Vaidyanathan Viswanath VSU
- Adam Polonek MGB
- Nicola Cadei SUB
- Yuhong Geng SUB
- Jubo Liu SUB
- Ramesh Rajentheran SUB
- Tomasz Siembida SUB
- Khee Wee Hau SUB
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 2nd, 2004
- Public Since
- March 16th, 2005
- No. of Employees
- 363
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Warsaw Stock Exchange- Shares in Issue
- 85,864,200
- Address
- ul. Staroscinska 5, WARSZAWA, 02-516
- Web
- https://bioton.com/
- Phone
- +48 227214000
- Contact
- Katarzyna Stalinska
- Auditors
- UHY ECA Audyt Sp. Zoo SP. k.
Upcoming Events for BIO
Similar to BIO
Braster SA
Warsaw Stock Exchange
Captor Therapeutics SA
Warsaw Stock Exchange
Genomed SA
Warsaw Stock Exchange
Genomtec SA
Warsaw Stock Exchange
Hyenergy SA
Warsaw Stock Exchange
FAQ
As of Today at 19:36 UTC, shares in Bioton SA are trading at PLN3.70. This share price information is delayed by 15 minutes.
Shares in Bioton SA last closed at PLN3.70 and the price had moved by +7.14% over the past 365 days. In terms of relative price strength the Bioton SA share price has outperformed the FTSE Global All Cap Index by +4.46% over the past year.
There is no consensus recommendation for this security.
Find out moreBioton SA does not currently pay a dividend.
Bioton SA does not currently pay a dividend.
Bioton SA does not currently pay a dividend.
To buy shares in Bioton SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN3.70, shares in Bioton SA had a market capitalisation of PLN317.70m.
Here are the trading details for Bioton SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: BIO
Based on an overall assessment of its quality, value and momentum Bioton SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioton SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +11.96%.
As of the last closing price of PLN3.70, shares in Bioton SA were trading +7.52% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bioton SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN3.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Bioton SA's management team is headed by:
- Jeremy Launders - CMG
- Dariusz Trzeciak - VSU
- Vaidyanathan Viswanath - VSU
- Adam Polonek - MGB
- Nicola Cadei - SUB
- Yuhong Geng - SUB
- Jubo Liu - SUB
- Ramesh Rajentheran - SUB
- Tomasz Siembida - SUB
- Khee Wee Hau - SUB